Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 217 Precursor Cell Lymphoblastic Leukemia-Lymphoma 192 Lymphoma, Large B-Cell, Diffuse 173 Burkitt Lymphoma 91 Lymphoma, Non-Hodgkin 90 Leukemia 80 Lymphoma, Follicular 79 Lymphoma, Mantle-Cell 53 Hodgkin Disease 46 Lymphoma, B-Cell 31 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30 Lymphoma, Large-Cell, Anaplastic 29 Lymphoma, T-Cell, Peripheral 28 Lymphoma, Large-Cell, Immunoblastic 27 Recurrence 24 Lymphoma, B-Cell, Marginal Zone 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Lymphoma, T-Cell 17 Leukemia, Biphenotypic, Acute 17 Dendritic Cell Sarcoma, Interdigitating 17 Immunoblastic Lymphadenopathy 16 Neoplasms 14 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11 HIV Infections 10 Waldenstrom Macroglobulinemia 7 Enteropathy-Associated T-Cell Lymphoma 7 Blast Crisis 7 Multiple Myeloma 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, AIDS-Related 6

Interventions

obinutuzumab 2 venetoclax 1 ofatumumab 1 neratinib 1 idelalisib 1 ibrutinib 1 Vindesine 1 Vincristine 1 Triamcinolone Acetonide 1 Transcatheter Aortic Valve Replacement 1 Th1-Th2 Balance 1 Surveys and Questionnaires 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Mechlorethamine 1 Interviews as Topic 1 HIV Testing 1 Doxorubicin 1 Diffusion Magnetic Resonance Imaging 1 Cyclophosphamide 1 Bleomycin 1 Bexarotene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Vincristine × Lymphoid × Clear all

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡